Showing results (301-310 of 367) with videos related to
Sort By:
Pageof 37
Journal of Medical Economics|August 6, 2021
Economic value of vaccines to address the COVID-19 pandemic: a U.S. cost-effectiveness and budget impact analysisWilliam V Padula, Shreena Malaviya, Natalie M Reid, et al.Scientific Reports|August 18, 2021
Dipeptidyl peptidase-4 inhibitor cardiovascular safety in patients with type 2 diabetes, with cardiovascular and renal disease: a retrospective cohort studySheriza Baksh, Jiajun Wen, Omar Mansour, et al.Drug and Alcohol Dependence|January 19, 2016
Effect of a "pill mill" law on opioid prescribing and utilization: The case of TexasTatyana Lyapustina, Lainie Rutkow, Hsien-Yen Chang, et al.Journal of the American Heart Association|April 27, 2022
National Trends in Use of Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists by Cardiologists and Other Specialties, 2015 to 2020Rishav Adhikari, Kunal Jha, Zeina Dardari, et al.BMC Health Services Research|January 1, 2013
Unsupported off-label chemotherapy in metastatic colon cancerJonas A de Souza, Blase Polite, Monica Perkins, et al.Contemporary Clinical Trials|July 17, 2024
Underrepresentation of black individuals in pivotal trials for novel anticancer drugs: Potential consequence of using estimated creatinine clearance to assess kidney function?Morgan A Butrovich, Allison C Reaves, Jamie Heyward, et al.Journal of Managed Care & Specialty Pharmacy|March 23, 2016
Using Certification to Promote Uptake of Real-World Evidence by PayersJodi B Segal, Joel D Kallich, Emma R Oppenheim, et al.Clinical Journal of the American Society of Nephrology : CJASN|February 1, 2023
Inclusion of Participants with CKD and Other Kidney-Related Considerations during Clinical Drug Development: Landscape Analysis of Anticancer Agents Approved from 2015 to 2019Morgan A Butrovich, Allison C Reaves, Jamie Heyward, et al.The Journal of Allergy and Clinical Immunology|February 5, 2023
Comparative effectiveness of omalizumab, mepolizumab, and dupilumab in asthma: A target trial emulationAyobami T Akenroye, Jodi B Segal, Guohai Zhou, et al.British Journal of Clinical Pharmacology|June 18, 2026
Evaluating effectiveness of risk minimization through healthcare professional surveys: A review of post-authorization studies, 2022-2024Kexin Zhu, William A Blumentals, Froilan G Celzo, et al.Pageof 37